Synergistic Effects of PPARgamma Ligands and Retinoids in Cancer Treatment.
about
The retinoid X receptors and their ligandsPeroxisome proliferator-activated receptor-gamma activation inhibits tumor metastasis by antagonizing Smad3-mediated epithelial-mesenchymal transitionPuerarin Protects against Cardiac Fibrosis Associated with the Inhibition of TGF-β1/Smad2-Mediated Endothelial-to-Mesenchymal Transition.Peroxisome proliferator-activated receptors and cancer: challenges and opportunitiesThe Key to Unlocking the Chemotherapeutic Potential of PPARγ Ligands: Having the Right Combination.PPARgamma and Proline Oxidase in Cancer.Strategy and mechanism for the prevention of hepatocellular carcinoma: phosphorylated retinoid X receptor alpha is a critical target for hepatocellular carcinoma chemoprevention.Peroxisome proliferator-activated receptor γ and colorectal cancer.PPAR gamma, bioactive lipids, and cancer progression.Acyclic retinoid in chemoprevention of hepatocellular carcinoma: Targeting phosphorylated retinoid X receptor-α for prevention of liver carcinogenesis.Combinational effect of PPARγ agonist and RXR agonist on the growth of SGC7901 gastric carcinoma cells in vitro.PPARs: Interference with Warburg' Effect and Clinical Anticancer Trials.Involvement of the Retinoid X Receptor Ligand in the Anti-Inflammatory Effect Induced by Peroxisome Proliferator-Activated Receptor γ Agonist In Vivo.PPARgamma and RXRgamma ligands act synergistically as potent antineoplastic agents in vitro and in vivo glioma models.Peroxisome proliferator-activated receptor gamma ligands enhance human B cell antibody production and differentiation.
P2860
Q24562747-CEDBB8B3-E049-4C84-B879-79E3AA5D500FQ30498249-F1723D4C-E5A8-4487-A86D-E93A2A054722Q33790719-4242F50A-E826-41A3-B584-40BE69896761Q35210023-B526A254-634B-4B3D-8734-2F198500CEDAQ36090448-1F1E31F5-BE37-4E1F-B30E-3EAEEEA8E650Q36798663-FE1C8BFB-F4C3-4478-A99A-3AD33E42B01FQ37345052-CD31C5F8-D296-4658-8326-CB56166C57D0Q37821269-9837C020-C507-47DA-97FD-89273489DE83Q37971590-741CB54C-83D3-4809-BBA0-EEFD524F29EDQ38066478-CCADE845-85C4-4E23-BF9A-6DF91E4C5BA3Q39162746-528131AD-AF3F-4E56-8AE6-2F88C5E52EB7Q39609137-7B81689D-8CFD-4E9D-B641-1A1950A03BF5Q39750509-9DB21DAF-D36F-42D9-A6BC-1CFE9932F463Q39849095-B4C250B6-AF8B-4678-B3B9-62CDCED011E3Q42210954-9C748FF1-EE3F-4A51-9E8F-B1236E946213
P2860
Synergistic Effects of PPARgamma Ligands and Retinoids in Cancer Treatment.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on January 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Synergistic Effects of PPARgamma Ligands and Retinoids in Cancer Treatment.
@en
Synergistic Effects of PPARgamma Ligands and Retinoids in Cancer Treatment.
@nl
type
label
Synergistic Effects of PPARgamma Ligands and Retinoids in Cancer Treatment.
@en
Synergistic Effects of PPARgamma Ligands and Retinoids in Cancer Treatment.
@nl
prefLabel
Synergistic Effects of PPARgamma Ligands and Retinoids in Cancer Treatment.
@en
Synergistic Effects of PPARgamma Ligands and Retinoids in Cancer Treatment.
@nl
P2860
P356
P1433
P1476
Synergistic Effects of PPARgamma Ligands and Retinoids in Cancer Treatment.
@en
P2093
Hisataka Moriwaki
Masahito Shimizu
P2860
P304
P356
10.1155/2008/181047
P577
2008-01-01T00:00:00Z